77 related articles for article (PubMed ID: 7971249)
1. Balance between human peripheral blood CFU-GEMM and CFU-Meg in sustained and acute thrombocytopenia.
Sumereau-Dassin E; Goulamhoussen T; Breton P
Nouv Rev Fr Hematol (1978); 1994 Aug; 36(4):301-5. PubMed ID: 7971249
[TBL] [Abstract][Full Text] [Related]
2. Megakaryocytopoiesis in the rat: response to thrombocytopenia induced by exchange transfusion.
Kimura H; Segal GM; Lee MY; Adamson JW
Exp Hematol; 1985 Nov; 13(10):1048-54. PubMed ID: 4054245
[TBL] [Abstract][Full Text] [Related]
3. Circulating megakaryocytes and their progenitors in early thrombocytopenia in preterm neonates.
Murray NA; Roberts IA
Pediatr Res; 1996 Jul; 40(1):112-9. PubMed ID: 8798256
[TBL] [Abstract][Full Text] [Related]
4. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-3 followed by GM-CSF for delayed engraftment after autologous bone marrow transplantation.
Crump M; Couture F; Kovacs M; Saragosa R; McCrae J; Brandwein J; Huebsch L; Beauregard-Zollinger L; Keating A
Exp Hematol; 1993 Mar; 21(3):405-410. PubMed ID: 8440338
[TBL] [Abstract][Full Text] [Related]
6. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
[TBL] [Abstract][Full Text] [Related]
7. Effect of cytokine treatment (granulocyte colony-stimulating factor and stem cell factor) on hematopoiesis and the circulating pool of hematopoietic stem cells in mice.
Drize N; Chertkov J; Samoilina N; Zander A
Exp Hematol; 1996 Jun; 24(7):816-22. PubMed ID: 8647232
[TBL] [Abstract][Full Text] [Related]
8. In vitro sensitivity of human hematopoietic progenitor cells to 4-hydroperoxycyclophosphamide.
Ratajczak MZ; Ratajczak J; Kuczynski W; Light B; Lusk EJ; Gewirtz AM
Exp Hematol; 1993 Dec; 21(13):1663-7. PubMed ID: 8243568
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human c-Mpl ligand (thrombopoietin) not only acts on megakaryocyte progenitors, but also on erythroid and multipotential progenitors in vitro.
Tanimukai S; Kimura T; Sakabe H; Ohmizono Y; Kato T; Miyazaki H; Yamagishi H; Sonoda Y
Exp Hematol; 1997 Sep; 25(10):1025-33. PubMed ID: 9293899
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy-induced thrombocytopenia derives from the selective death of megakaryocyte progenitors and can be rescued by stem cell factor.
Zeuner A; Signore M; Martinetti D; Bartucci M; Peschle C; De Maria R
Cancer Res; 2007 May; 67(10):4767-73. PubMed ID: 17510405
[TBL] [Abstract][Full Text] [Related]
11. Kinetics of hematopoiesis in Dexter-type long-term cultures established from human umbilical cord blood cells.
Mayani H; Gutiérrez-Rodríguez M; Espinoza L; López-Chalini E; Huerta-Zepeda A; Flores E; Sánchez-Valle E; Luna-Bautista F; Valencia I; Ramírez OT
Stem Cells; 1998; 16(2):127-35. PubMed ID: 9554037
[TBL] [Abstract][Full Text] [Related]
12. Very large amounts of peripheral blood progenitor cells eliminate severe thrombocytopenia after high-dose melphalan in advanced breast cancer patients.
Benedetti G; Patoia L; Giglietti A; Alessio M; Pelicci P; Grignani F
Bone Marrow Transplant; 1999 Nov; 24(9):971-9. PubMed ID: 10556956
[TBL] [Abstract][Full Text] [Related]
13. Growth characteristics of circulating hematopoietic progenitors in terminal renal failure.
Glaser M
Med Sci Monit; 2006 Mar; 12(3):CR113-7. PubMed ID: 16501421
[TBL] [Abstract][Full Text] [Related]
14. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
15. Hematopoiesis during acute Toxoplasma gondii infection in mice.
Petakov M; Stojanović N; Jovcić G; Bugarski D; Todorović V; Djurković-Djaković O
Haematologia (Budap); 2002; 32(4):439-55. PubMed ID: 12803118
[TBL] [Abstract][Full Text] [Related]
16. Special Education.
Kozutsumi H
Oncologist; 1996; 1(1 & 2):116-118. PubMed ID: 10387976
[TBL] [Abstract][Full Text] [Related]
17. Influence of rhG-CSF scheduling on megakaryocytopoietic recovery following 5-fluorouracil-induced hematotoxicity in splenectomized B6D2F1 mice.
Scheding S; Media JE; Nakeff A
Stem Cells; 1998; 16(2):144-51. PubMed ID: 9554039
[TBL] [Abstract][Full Text] [Related]
18. Graft clonogenicity and intensity of pre-treatment: factors affecting outcome of autologous peripheral hematopoietic cell transplantation in patients with acute myeloid leukemia in first remission.
Strodtbeck D; Bornhäuser M; Hänel M; Lerche L; Schaich M; Illmer T; Thiede C; Geissler G; Herbst R; Ehninger G; Platzbecker U
Bone Marrow Transplant; 2005 Dec; 36(12):1083-8. PubMed ID: 16247435
[TBL] [Abstract][Full Text] [Related]
19. Enforced TAL-1 expression stimulates primitive, erythroid and megakaryocytic progenitors but blocks the granulopoietic differentiation program.
Valtieri M; Tocci A; Gabbianelli M; Luchetti L; Masella B; Vitelli L; Botta R; Testa U; Condorelli GL; Peschle C
Cancer Res; 1998 Feb; 58(3):562-9. PubMed ID: 9458106
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow failure following severe injury in humans.
Livingston DH; Anjaria D; Wu J; Hauser CJ; Chang V; Deitch EA; Rameshwar P
Ann Surg; 2003 Nov; 238(5):748-53. PubMed ID: 14578739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
